Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on November 24, 2004
J Am Soc Nephrol 16: 109-116, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004060495

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004060495v1
16/1/109    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Massy, Z. A.
Right arrow Articles by Muntzel, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massy, Z. A.
Right arrow Articles by Muntzel, M. S.

Basic Mineral Metabolism

Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice

Ziad A. Massy*,§, Ognen Ivanovski*, Thao Nguyen-Khoa*,{dagger}, Jesus Angulo{ddagger}, Dorota Szumilak*, Nadya Mothu*, Olivier Phan*, Michel Daudon{dagger}, Bernard Lacour{dagger}, Tilman B. Drüeke* and Martin S. Muntzel||

* INSERM Unit 507 and {dagger} Laboratory of Biochemistry A, Necker Hospital, Paris, and {ddagger} Centre de Morphologie Mathématique, Ecole des Mines, Fontainebleau, France; and § Divisions of Clinical Pharmacology and Nephrology, University of Picardie and Amiens University Hospital, Amiens; and || Department of Biological Sciences, Lehman College, Bronx, New York

Address correspondence to: Dr. Ziad A. Massy, INSERM Unit 507, Necker Hospital, 161, Rue de Sèvres 75015 Paris, France. Phone: + 33-1-44-49-52-34; Fax: + 33-1-45-66-51-33; E-mail: massy{at}u-picardie.fr

Chronic renal failure (CRF) favors the development of atherosclerosis and excessive calcification of atheromatous lesions. CRF was induced in apolipoprotein E knockout (apoE–/–) mice to study (1) a possible acceleration of aortic atherosclerosis, (2) the degree and type of vascular calcification, and (3) factors involved in the calcification process. For creating CRF, 8-wk-old apolipoprotein E gene knockout (apoE–/–) mice underwent partial kidney ablation. Control animals underwent sham operation. Aortic atherosclerotic plaques and calcification were evaluated using quantitative morphologic image processing. At 6 wk after nephrectomy, CRF mice had significantly higher serum urea, cholesterol, and triglyceride concentrations than non-CRF controls. The serum levels of advanced oxidation protein products were elevated in the uremic group and were correlated with serum urea levels. Atherosclerotic lesions in thoracic aorta were significantly larger in uremic apoE–/– mice than in nonuremic controls. The relative proportion of calcified area to total surface area of both atherosclerotic lesions and lesion-free vascular tissue was increased in aortic root of uremic apoE–/– mice when compared with controls. The calcium deposits were made of hydroxyapatite and calcite crystals. In addition, plaques from uremic animals showed a significant increase in collagen content, whereas the degree of macrophage infiltration was comparable in both groups. There was no difference in mean arterial BP. These findings demonstrate that CRF aggravates atherosclerosis in apoE–/– mice. Moreover, CRF enhances arterial calcification at both atheromatous intimal sites and atheroma-free medial sites. We anticipate that this experimental model will be useful to test treatment strategies aimed at decreasing the accelerated atherosclerosis and arterial calcification in uremia




This article has been cited by other articles:


Home page
CJASNHome page
K. Amann
Media Calcification and Intima Calcification Are Distinct Entities in Chronic Kidney Disease
Clin. J. Am. Soc. Nephrol., November 1, 2008; 3(6): 1599 - 1605.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Mathew, R. J. Lund, L. R. Chaudhary, T. Geurs, and K. A. Hruska
Vitamin D Receptor Activators Can Protect against Vascular Calcification
J. Am. Soc. Nephrol., August 1, 2008; 19(8): 1509 - 1519.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. Phan, O. Ivanovski, I. G. Nikolov, N. Joki, J. Maizel, L. Louvet, M. Chasseraud, T. Nguyen-Khoa, B. Lacour, T. B. Drueke, et al.
Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 82 - 90.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. A. Bang, S. Bro, E. D. Bartels, T. X. Pedersen, and L. B. Nielsen
Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1325 - F1331.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Westenfeld, C. Schafer, R. Smeets, V. M. Brandenburg, J. Floege, M. Ketteler, and W. Jahnen-Dechent
Fetuin-A (AHSG) prevents extraosseous calcification induced by uraemia and phosphate challenge in mice
Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1537 - 1546.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Bro, C. J. Binder, J. L. Witztum, K. Olgaard, and L. B. Nielsen
Inhibition of the Renin-Angiotensin System Abolishes the Proatherogenic Effect of Uremia in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1080 - 1086.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Krasniak, M. Drozdz, M. Pasowicz, G. Chmiel, M. Michalek, D. Szumilak, P. Podolec, P. Klimeczek, M. Konieczynska, E. Wicher-Muniak, et al.
Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 515 - 521.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
I. Nikolov, N. Joki, T. Drueke, and Z. Massy
Beyond phosphate--role of uraemic toxins in cardiovascular calcification
Nephrol. Dial. Transplant., December 1, 2006; 21(12): 3354 - 3357.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Ritz and C. Wanner
Lipid Changes and Statins in Chronic Renal Insufficiency
J. Am. Soc. Nephrol., December 1, 2006; 17(12_suppl_3): S226 - S230.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
K. Amann, C. Wanner, and E. Ritz
Cross-Talk between the Kidney and the Cardiovascular System
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2112 - 2119.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Bro, R. Borup, C. B. Andersen, F. Moeller, K. Olgaard, and L. B. Nielsen
Uremia-Specific Effects in the Arterial Media During Development of Uremic Atherosclerosis in Apolipoprotein E-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 570 - 575.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
R. Karra, S. Vemullapalli, C. Dong, E.E. Herderick, X. Song, K. Slosek, J.R. Nevins, M. West, P.J. Goldschmidt-Clermont, D. Seo, et al.
Stem Cells of Aging Donors--Insufficient Capacity to Repair Causes Progression of Atherosclerosis in the Recipient: Molecular Evidence for Arterial Repair in Atherosclerosis. Proc Natl Acad Sci U S A 102: 16789-16794, 2005
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 317 - 322.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Suganuma, Y. Zuo, N. Ayabe, J. Ma, V. R. Babaev, M. F. Linton, S. Fazio, I. Ichikawa, A. B. Fogo, and V. Kon
Antiatherogenic Effects of Angiotensin Receptor Antagonism in Mild Renal Dysfunction
J. Am. Soc. Nephrol., February 1, 2006; 17(2): 433 - 441.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Hyafil, J.-P. Laissy, M. Mazighi, D. Tchetche, L. Louedec, H. Adle-Biassette, S. Chillon, D. Henin, M.-P. Jacob, D. Letourneur, et al.
Ferumoxtran-10-Enhanced MRI of the Hypercholesterolemic Rabbit Aorta: Relationship Between Signal Loss and Macrophage Infiltration
Arterioscler. Thromb. Vasc. Biol., January 1, 2006; 26(1): 176 - 181.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Zhang, A. Zhang, D.E. Kohan, R.D. Nelson, F.J. Gonzales, T. Yang, C. Schmidt-Lucke, L. Rossig, S. Fichtlscherer, M. Vasa, et al.
Edema and Congestive Heart Failure from Thiazolidone Insulin Sensitizers--Excess Sodium Reabsoption in the Collecting Duct: Collecting Duct-Specific Deletion of Peroxisome Proliferator-Activated Receptor {gamma} Blocks Thiazolidinedione-Induced Fluid Retention. Proc Nat Acad Sci U S A 102: 9406-9411, 2005
J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3139 - 3142.
[Full Text] [PDF]


Home page
CirculationHome page
O. Phan, O. Ivanovski, T. Nguyen-Khoa, N. Mothu, J. Angulo, R. Westenfeld, M. Ketteler, N. Meert, J. Maizel, I. G. Nikolov, et al.
Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E-Deficient Mice
Circulation, November 1, 2005; 112(18): 2875 - 2882.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP